These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7604818)

  • 21. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
    Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
    N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to activated protein C and factor V Leiden.
    Perry DJ; Pasi KJ
    QJM; 1997 Jun; 90(6):379-85. PubMed ID: 9205675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C.
    Williamson D; Brown K; Luddington R; Baglin C; Baglin T
    Blood; 1998 Feb; 91(4):1140-4. PubMed ID: 9454742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor V Leiden (R506Q) and risk of venous thromboembolism: a case-control study based on the Spanish population.
    García-Gala JM; Alvarez V; Pinto CR; Soto I; Urgellés MF; Menéndez MJ; Carracedo C; López-Larrea C; Coto E
    Clin Genet; 1997 Oct; 52(4):206-10. PubMed ID: 9383024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C].
    Lew Andowski KL; Rozek M; Turowiecka Z; Markiewicz WT; Zawilska K
    Pol Arch Med Wewn; 1996 May; 95(5):464-70. PubMed ID: 8848415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
    Hirsch DR; Mikkola KM; Marks PW; Fox EA; Dorfman DM; Ewenstein BM; Goldhaber SZ
    Am Heart J; 1996 Jun; 131(6):1145-8. PubMed ID: 8644593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of three reactants for the detection of activated protein C resistance due to mutation of factor V Leiden during pregnancy].
    Magdelaine A; Soubrier F; Berkane N; Uzan S; Verdy E
    Ann Biol Clin (Paris); 1998; 56(4):445-50. PubMed ID: 9754280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
    Nafa K; Bessler M; Mason P; Vulliamy T; Hillmen P; Castro-Malaspina H; Luzzatto L
    Haematologica; 1996; 81(6):540-2. PubMed ID: 9009443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the prevalence of the factor V Leiden mutation in patients with pulmonary embolism and deep vein thrombosis really different?
    Turkstra F; Karemaker R; Kuijer PM; Prins MH; Büller HR
    Thromb Haemost; 1999 Mar; 81(3):345-8. PubMed ID: 10102457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simple and rapid detection of factor V Leiden by allele-specific PCR amplification.
    Blasczyk R; Ritter M; Thiede C; Wehling J; Hintz G; Neubauer A; Riess H
    Thromb Haemost; 1996 May; 75(5):757-9. PubMed ID: 8725719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis.
    Dizon-Townson DS; Nelson LM; Jang H; Varner MW; Ward K
    Am J Obstet Gynecol; 1997 Apr; 176(4):883-6. PubMed ID: 9125615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to activated protein C caused by a factor V gene mutation.
    Zöller B; Dahlbäck B
    Curr Opin Hematol; 1995 Sep; 2(5):358-64. PubMed ID: 9372020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of factor V Leiden in Thai patients with venous thrombosis.
    Prayoonwiwat W; Arnutti P; Hiyoshi M; Nathalang O; Suwanasophon C; Kokaseam R; Krutvecho T; Tatsumi N
    Asian Pac J Allergy Immunol; 2000 Jun; 18(2):105-8. PubMed ID: 10928623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.
    Hallak M; Senderowicz J; Cassel A; Shapira C; Aghai E; Auslender R; Abramovici H
    Am J Obstet Gynecol; 1997 Apr; 176(4):889-93. PubMed ID: 9125617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
    Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Eisenberg PR; Miletich JP
    N Engl J Med; 1995 Apr; 332(14):912-7. PubMed ID: 7877648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.